Stroke and Ischemic Heart Disease With Enzyme-inducing Antiseizure Medications: Time to Change Prescribing Habits
Conclusions and Relevance: The hazard of incident cardiovascular disease is higher in those receiving eiASMs. The association is dose dependent and the absolute difference in hazard seems to reach clinical significance by approximately 10 years from first exposure.PMID:35444497 | PMC:PMC8988723 | DOI:10.1177/15357597211070392
Source: Epilepsy Currents - Category: Neurology Authors: David G Vossler Source Type: research
More News: Carbamazepine | Cardiology | Cardiovascular | Electronic Health Records (EHR) | Epilepsy | Heart | Heart Disease | Hemorrhagic Stroke | Inovelon | Ischemic Stroke | Neurology | Phenobarbital | Phenytoin | Primary Care | Rufinamide | Stroke | Study | Topamax | UK Health